Psychology TodayGLP-1 treatments challenge the belief that weight management relies on willpower
How protein took over the supermarket
The New York TimesSep 28, 2026
The most talked-about drug class began with a desert lizard
Clinics in DermatologySep 16, 2026
GLP-1 drugs cut food noise in half, but clinicians warn hunger cues remain essential
Women's HealthSep 2, 2026
When a parent’s body changes, children notice
CNNAug 17, 2026
GLP-1 use for weight loss nearly quadrupled in two years
New York PostJul 18, 2026
A 2026 national survey found that 11% of adults reported currently using a GLP-1 medicine for weight loss
The National News DeskJul 8, 2026
GLP-1 medicines joined America's long weight-loss history instead of replacing it
The AtlanticFeb 2023
ClinicalTrials.govSep 28, 2026
A GLP-1 medicine is being tested against methamphetamine addiction
Researchers at the University of Texas Southwestern have completed a pilot study of tirzepatide in adults who have both obesity and moderate to severe methamphetamine use disorder. The study planned for up to 45 participants. Everyone received the medicine once a week for 32 weeks, prescribed for its approved weight use, with weekly clinic visits and a four-week follow-up. The phase 2 study had no comparison group; it was built to test whether such a trial is feasible and to look for early signs of an effect.
A designed enzyme shows where protein engineering is heading
ScienceJul 16, 2026
A GLP-1 implant is testing a different delivery idea, not offering a new option yet
CNBC Health and ScienceJul 11, 2026
The cancer question around GLP-1 medicines is still early
PBS News HourJun 19, 2026
Protein design is expanding the research toolkit behind future medicines
TED (David Baker)Jun 2025
